NATCO PHARMA LTD. - NATCO receives USFDA tentative approval for Sorafenib Tablets, 200mg

03 Jun 2016

Natco Pharma Ltd has informed BSE regarding a Press Release dated June 03, 2016 titled "NATCO receives USFDA tentative approval for Sorafenib Tablets, 200mg".

Source: BSE India

View all announcements for NATCO PHARMA LTD.

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist